Overview:

The Neuropathic Pain Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries, as available worldwide. Information specific to diabetic neuropathies and postherpetic neuralgia are covered in-depth. Other types of neuropathic pain, such as neuropathic pain associated with HIV/AIDS, is also discussed. Diagnosis of neuropathic pain is covered, along with information on treatment options approved by the FDA for the treatment of neuropathic pain. Dosing for commonly used medications is provided, along with treatment costs of FDA approved neuropathic pain medications. Market size estimates and annual sales of leading therapies are provided.

Additional Information

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

I. OVERVIEW
General description of the condition
Types of neuropathic pain
Diabetic neuropathies
Post-herpetic neuralgia (PHN)

II. INCIDENCE AND PREVALENCE
Incidence Table-Diabetic Neuropathy (UK)
Prevalence Table-Diabetic Neuropathy (US, UK, Italy, Worldwide)
Neuropathic pain associated with HIV/AIDS
Postherpetic neuralgia

III. DIAGNOSIS
Patient history
Diagnostic tools

IV. TREATMENT AND DOSING
Commonly prescribed medications
Dosing

V. TREATMENT COSTS

VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals
Future therapies

VII. COMMENTS

VIII. REFERENCES/RESOURCES